IN SILICO DISCOVERY OF NDM-1 METALLO--LACTAMASE INHIBITORS. Questo articolo non è disponibile.
Lingua: inglese
Editore: LAP LAMBERT Academic Publishing, 2026
- Brossura
- Nuovo

Da: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US
Venditore con 5 stelle
Venditore AbeBooks dal 7 aprile 2005
Non disponibile
Brossura
Condizione: Nuovo
EUR 61,59
Descrizione dell’articolo da parte del venditore
New Book. Shipped from UK. Established seller since 2000.
Codice articolo L2-9786630056426
- Titolo
- IN SILICO DISCOVERY OF NDM-1 METALLO--LACTAMASE INHIBITORS
- Autore
- S, Raghavendra
- Editore
- LAP LAMBERT Academic Publishing
- Anno di pubblicazione
- 2026
- Condizione
- New
- Rilegatura
- PAP
- Lingua
- inglese
- ISBN 10
- 6630056426
- ISBN 13
- 9786630056426
- Peso dell'articolo
- 96 grammi
This book presents a comprehensive in silico drug discovery study focused on identifying potential inhibitors of New Delhi metallo-β-lactamase-1 (NDM-1), a key enzyme responsible for extensive β-lactam antibiotic resistance in Klebsiella pneumoniae. The work addresses the growing global threat of antimicrobial resistance and emphasizes the urgent need for novel therapeutic strategies against NDM-1-producing pathogens.The study follows a systematic computational workflow that includes protein retrieval and active-site identification, molecular docking, virtual screening, ADMET and toxicity prediction, and molecular dynamics (MD) simulations. The crystal structure of NDM-1 (PDB ID: 6NY7) was used as the target protein, and docking model validation was performed using the native ligand interactions.The findings conclude that the identified sulfonamide derivatives exhibit strong binding affinity, favorable ADME profiles, low toxicity, and stable interaction with NDM-1. The book establishes these compounds as potential lead candidates for further experimental validation and development against infections caused by NDM-1-producing Klebsiella pneumoniae.
"Riassunto" può appartenere a un’altra edizione di questo titolo.